Nalaganje...
The evolution of S100B inhibitors for the treatment of malignant melanoma
Malignant melanoma continues to be an extremely fatal cancer due to a lack of viable treatment options for patients. The calcium-binding protein S100B has long been used as a clinical biomarker, aiding in malignant melanoma staging and patient prognosis. However, the discovery of p53 as a S100B targ...
Shranjeno v:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2013
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3575173/ https://ncbi.nlm.nih.gov/pubmed/23256816 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/fmc.12.191 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|